Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection
Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection
Randomized open label clinical trial to compare the clinical and microbiological efficacy of
 fecal microbiota transplantation, fidaxomicin, and vancomycin for relapsing Clostridium
 difficile infection
Inclusion Criteria:

 1. Relapse of Clostridium difficile infection with previous trial of vancomycin or
 fidaxomicin

 Exclusion Criteria:

 1. Pregnancy or breastfeeding

 2. Does not speak or understand the Danish language

 3. Current antibiotic treatment other than metronidazole, vancomycin, fidaxomicin

 4. fulminant colitis which contraindicates medical treatment

 5. physician's evaluation that the patient cannot tolerate project inclusion